CD4 and neoplasm: Research has found that Th1-type cell-directed CD4+ T cells reprogram bone marrow cells of the tumor to express interferon-activated antigen presentation and iNOS-mediated tumor-killing phenotype, thereby inducing the immune-escape tumor to undergo inflammatory cell death [43].